SHA:603334 Market Cap

SHA:603334 has a market cap or net worth of 7.93 billion as of March 9, 2026.

Market Cap

7.93B

Enterprise Value

8.20B

Revenue

2.81B

Ranking

n/a

PE Ratio

38.71

Stock Price

55.29

Market Cap Chart

Since November 5, 2025, SHA:603334's market cap has decreased from 9.58B to 7.93B, a decrease of -17.18%. That is a compound annual growth rate of -42.59%.

Market Cap History

Date	Market Cap	% Change
Mar 9, 2026	7.93B	32.27%
Dec 31, 2025	6.00B	-37.39%

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Anhui Huaheng Biotechnology	7.99B
Zhejiang Ausun Pharmaceutical	7.83B
Nanjing Vazyme Biotech	8.06B
Chengdu Kanghua Biological Products	8.08B
Jiangxi Fushine Pharmaceutical	8.25B
Acrobiosystems	7.53B
Youcare Pharmaceutical Group	8.43B
Wuhan Keqian Biology Co.,Ltd	7.43B

Market Cap Rankings